FDA panel rejects experimental weight loss pill
Thursday, July 15, 2010 - 17:14
in Health & Medicine
(AP) -- A panel of federal health experts dealt a surprising setback Thursday to a highly anticipated anti-obesity pill from Vivus Inc., saying the drug's side effects outweigh its ability to help patients lose weight.